Article

Reuters Health Information: June 2008

Neurology Reviews. 2008 June;16(6):17, 18, 19

 

Compared with placebo, low-dose istradefylline reduced the percentage “off” time by 4.35%, and the high dose reduced it by 4.49%. The benefits of istradefylline persisted throughout the 12-week study.

Neurology. 2008;70(23):2233-2240.

Pages

Recommended Reading

Lipid-Lowering Drugs Reversed Cognitive Decline : At 1 year, active therapy significantly improved patients' memory and speed of data processing.
MDedge Neurology
Cerebral Perfusion Is Low in Hypertensive Alzheimer's
MDedge Neurology
Transient Neurological Attacks Raise Vascular Risk
MDedge Neurology
Advances in Neurogenetics, Neuromics Aid Understanding of Neurologic Disorders
MDedge Neurology
News Roundup
MDedge Neurology
Study Validates Pittsburgh Compound-B for In Vivo Diagnosis of Alzheimer's Disease
MDedge Neurology
Longevity Genotype Is Associated With Preservation of Cognitive Function
MDedge Neurology
Depression May Increase the Risk of Alzheimer's Disease
MDedge Neurology
News Roundup
MDedge Neurology
Conjugal Alzheimer's Disease—Children at Risk When Both Parents Have a Positive Diagnosis
MDedge Neurology